Global Gene Editing Technology Market Size, Status and Forecast 2022-2028

Table Of Contents

1 Report Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Editing Technology Market Size Growth Rate by Type (2022-2028) 1.2.2 Homologous Recombination 1.2.3 Meganuclease 1.3 Market by Application 1.3.1 Global Gene Editing Technology Market Share by Application (2022-2028) 1.3.2 Agriculture 1.3.3 Medical 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Gene Editing Technology Market Size 2.2 Gene Editing Technology Market Size by Regions 2.2.1 Gene Editing Technology Growth Rate by Regions (2022-2028) 2.2.2 Gene Editing Technology Market Share by Regions (2022-2028) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases3 Key Players 3.1 Gene Editing Technology Revenue by Players (2022 & 2028) 3.2 Gene Editing Technology Key Players Headquarters and Area Served 3.3 Key Players Gene Editing Technology Product/Solution/Service 3.4 Date of Enter into Gene Editing Technology Market 3.5 Mergers & Acquisitions, Expansion Plans4 Breakdown by Type and by Application 4.1 Global Gene Editing Technology Market Size by Type (2022-2028) 4.2 Global Gene Editing Technology Market Size by Application (2022-2028)5 North America 5.1 North America Gene Editing Technology Market Forecast (2022-2028) 5.2 Gene Editing Technology Key Players in North America 5.3 North America Gene Editing Technology Market Size by Type 5.4 North America Gene Editing Technology Market Size by Application6 Europe 6.1 Europe Gene Editing Technology Market Forecast (2022-2028) 6.2 Gene Editing Technology Key Players in Europe 6.3 Europe Gene Editing Technology Market Size by Type 6.4 Europe Gene Editing Technology Market Size by Application7 Asia-Pacific 7.1 Asia-Pacific Gene Editing Technology Market Forecast (2022-2028) 7.2 Gene Editing Technology Key Players in Asia-Pacific 7.3 Asia-Pacific Gene Editing Technology Market Size by Type 7.4 Asia-Pacific Gene Editing Technology Market Size by Application8 Rest of World 8.1 Latin America 8.1.1 Latin America Gene Editing Technology Market Analysis 8.1.2 Key Players in Latin America 8.2 Middle East & Africa 8.2.1 Middle East & Africa Gene Editing Technology Market Analysis 8.2.2 Key Players in Middle East & Africa9 International Player Profiles 9.1 Thermo Fisher Scientific 9.1.1 Thermo Fisher Scientific Company Details 9.1.2 Thermo Fisher Scientific Description and Business Overview 9.1.3 Thermo Fisher Scientific Gene Editing Technology Introduction 9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technology Business (2022 & 2028) 9.1.5 Thermo Fisher Scientific Recent Development 9.2 SIGMA ALDRICH 9.2.1 SIGMA ALDRICH Company Details 9.2.2 SIGMA ALDRICH Description and Business Overview 9.2.3 SIGMA ALDRICH Gene Editing Technology Introduction 9.2.4 SIGMA ALDRICH Revenue in Gene Editing Technology Business (2022 & 2028) 9.2.5 SIGMA ALDRICH Recent Development 9.3 Dharmacon 9.3.1 Dharmacon Company Details 9.3.2 Dharmacon Description and Business Overview 9.3.3 Dharmacon Gene Editing Technology Introduction 9.3.4 Dharmacon Revenue in Gene Editing Technology Business (2022 & 2028) 9.3.5 Dharmacon Recent Development 9.4 Cellectics 9.4.1 Cellectics Company Details 9.4.2 Cellectics Description and Business Overview 9.4.3 Cellectics Gene Editing Technology Introduction 9.4.4 Cellectics Revenue in Gene Editing Technology Business (2022 & 2028) 9.4.5 Cellectics Recent Development 9.5 CRISPR Therapeutics 9.5.1 CRISPR Therapeutics Company Details 9.5.2 CRISPR Therapeutics Description and Business Overview 9.5.3 CRISPR Therapeutics Gene Editing Technology Introduction 9.5.4 CRISPR Therapeutics Revenue in Gene Editing Technology Business (2022 & 2028) 9.5.5 CRISPR Therapeutics Recent Development 9.6 AstraZeneca 9.6.1 AstraZeneca Company Details 9.6.2 AstraZeneca Description and Business Overview 9.6.3 AstraZeneca Gene Editing Technology Introduction 9.6.4 AstraZeneca Revenue in Gene Editing Technology Business (2022 & 2028) 9.6.5 AstraZeneca Recent Development 9.7 Bio Rad 9.7.1 Bio Rad Company Details 9.7.2 Bio Rad Description and Business Overview 9.7.3 Bio Rad Gene Editing Technology Introduction 9.7.4 Bio Rad Revenue in Gene Editing Technology Business (2022 & 2028) 9.7.5 Bio Rad Recent Development 9.8 Allele Biotech 9.8.1 Allele Biotech Company Details 9.8.2 Allele Biotech Description and Business Overview 9.8.3 Allele Biotech Gene Editing Technology Introduction 9.8.4 Allele Biotech Revenue in Gene Editing Technology Business (2022 & 2028) 9.8.5 Allele Biotech Recent Development 9.9 Recombinetics 9.9.1 Recombinetics Company Details 9.9.2 Recombinetics Description and Business Overview 9.9.3 Recombinetics Gene Editing Technology Introduction 9.9.4 Recombinetics Revenue in Gene Editing Technology Business (2022 & 2028) 9.9.5 Recombinetics Recent Development 9.10 Lonza 9.10.1 Lonza Company Details 9.10.2 Lonza Description and Business Overview 9.10.3 Lonza Gene Editing Technology Introduction 9.10.4 Lonza Revenue in Gene Editing Technology Business (2022 & 2028) 9.10.5 Lonza Recent Development 9.11 GE Healthcare 9.11.1 GE Healthcare Company Details 9.11.2 GE Healthcare Description and Business Overview 9.11.3 GE Healthcare Gene Editing Technology Introduction 9.11.4 GE Healthcare Revenue in Gene Editing Technology Business (2022 & 2028) 9.11.5 GE Healthcare Recent Development 9.12 Editas Medicine 9.12.1 Editas Medicine Company Details 9.12.2 Editas Medicine Description and Business Overview 9.12.3 Editas Medicine Gene Editing Technology Introduction 9.12.4 Editas Medicine Revenue in Gene Editing Technology Business (2022 & 2028) 9.12.5 Editas Medicine Recent Development 9.13 Agilent Technologies 9.13.1 Agilent Technologies Company Details 9.13.2 Agilent Technologies Description and Business Overview 9.13.3 Agilent Technologies Gene Editing Technology Introduction 9.13.4 Agilent Technologies Revenue in Gene Editing Technology Business (2022 & 2028) 9.13.5 Agilent Technologies Recent Development 9.14 QIAGEN NV 9.14.1 QIAGEN NV Company Details 9.14.2 QIAGEN NV Description and Business Overview 9.14.3 QIAGEN NV Gene Editing Technology Introduction 9.14.4 QIAGEN NV Revenue in Gene Editing Technology Business (2022 & 2028) 9.14.5 QIAGEN NV Recent Development10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints11 Key Findings in This Report12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details